Correlation Between Pfizer and Prime Number

Can any of the company-specific risk be diversified away by investing in both Pfizer and Prime Number at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Prime Number into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Prime Number Acquisition, you can compare the effects of market volatilities on Pfizer and Prime Number and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Prime Number. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Prime Number.

Diversification Opportunities for Pfizer and Prime Number

0.0

Correlation Coefficient

Pfizer  Prime Number

Pay attention - limited upside

The 3 months correlation between Pfizer and Prime is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Prime Number Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Number Acquisition and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Prime Number. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Number Acquisition has no effect on the direction of Pfizer i.e., Pfizer and Prime Number go up and down completely randomly.

Pair Corralation between Pfizer and Prime Number

If you would invest  1,057  in Prime Number Acquisition on September 12, 2024 and sell it today you would earn a total of  0.00  from holding Prime Number Acquisition or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Pfizer Inc  vs.  Prime Number Acquisition

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Prime Number Acquisition

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prime Number Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Prime Number is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Pfizer and Prime Number

The main advantage of trading using opposite Pfizer and Prime Number positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Prime Number can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Number will offset losses from the drop in Prime Number's long position.

The idea behind Pfizer Inc and Prime Number Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.